Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

V. Roy; A. K. Stewart; P. L. Bergsagel; A. Dispenzieri; K. Laumann; J. Allred; M. Q. Lacy; R. Fonseca; C. B. Reeder; S. Kumar; C. E. Rivera; M. A. Gertz; F. K. Buadi; S. R. Hayman; S. V. Rajkumar

doi:10.1038/bcj.2015.23

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

V. Roy, A. K. Stewart, P. L. Bergsagel, A. Dispenzieri, K. Laumann, J. Allred, M. Q. Lacy, R. Fonseca, C. B. Reeder, S. Kumar, C. E. Rivera, M. A. Gertz, F. K. Buadi, S. R. Hayman, S. V. Rajkumar

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English (US)
Article number	e294
Journal	Blood cancer journal
Volume	5
Issue number	3
DOIs	https://doi.org/10.1038/bcj.2015.23
State	Published - Mar 20 2015

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/bcj.2015.23

Cite this

Roy, V., Stewart, A. K., Bergsagel, P. L., Dispenzieri, A., Laumann, K., Allred, J., Lacy, M. Q., Fonseca, R., Reeder, C. B., Kumar, S., Rivera, C. E., Gertz, M. A., Buadi, F. K., Hayman, S. R., & Rajkumar, S. V. (2015). Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation. Blood cancer journal, 5(3), Article e294. https://doi.org/10.1038/bcj.2015.23

Roy, V, Stewart, AK, Bergsagel, PL , Dispenzieri, A, Laumann, K, Allred, J, Lacy, MQ , Fonseca, R, Reeder, CB, Kumar, S , Rivera, CE , Gertz, MA, Buadi, FK, Hayman, SR & Rajkumar, SV 2015, 'Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation', Blood cancer journal, vol. 5, no. 3, e294. https://doi.org/10.1038/bcj.2015.23

@article{bc661e5fc03d4ab4be7afc87132bd9af,

title = "Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation",

author = "V. Roy and Stewart, {A. K.} and Bergsagel, {P. L.} and A. Dispenzieri and K. Laumann and J. Allred and Lacy, {M. Q.} and R. Fonseca and Reeder, {C. B.} and S. Kumar and Rivera, {C. E.} and Gertz, {M. A.} and Buadi, {F. K.} and Hayman, {S. R.} and Rajkumar, {S. V.}",

year = "2015",

month = mar,

day = "20",

doi = "10.1038/bcj.2015.23",

language = "English (US)",

volume = "5",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

AU - Roy, V.

AU - Stewart, A. K.

AU - Bergsagel, P. L.

AU - Dispenzieri, A.

AU - Laumann, K.

AU - Allred, J.

AU - Lacy, M. Q.

AU - Fonseca, R.

AU - Reeder, C. B.

AU - Kumar, S.

AU - Rivera, C. E.

AU - Gertz, M. A.

AU - Buadi, F. K.

AU - Hayman, S. R.

AU - Rajkumar, S. V.

PY - 2015/3/20

Y1 - 2015/3/20

UR - http://www.scopus.com/inward/record.url?scp=84989347226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989347226&partnerID=8YFLogxK

U2 - 10.1038/bcj.2015.23

DO - 10.1038/bcj.2015.23

M3 - Letter

C2 - 25794130

AN - SCOPUS:84989347226

SN - 2044-5385

VL - 5

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - e294

ER -

Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this